Horacek JM - Search Results

1

Serum levels of soluble adhesion molecules in newly diagnosed acute myeloid leukemia and in complete remission suggest endothelial cell activation by myeloblasts.

Kupsa T, Vanek J, Pavel Z, Jebavy L, Horacek JM. Kupsa T, et al. Among authors: horacek jm. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Mar;161(1):92-99. doi: 10.5507/bp.2016.054. Epub 2016 Nov 10. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017. PMID: 27833171 Free article.

2

The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.

Horácek JM, Pudil R, Tichý M, Jebavý L, Strasová A, Praus R, Zák P, Malý J. Horácek JM, et al. Neoplasma. 2005;52(5):430-4. Neoplasma. 2005. PMID: 16151589

3

Anthracycline therapy can induce very early increase in QT dispersion and QTc prolongation.

Pudil R, Horacek JM, Horackova J, Jebavy L, Vojacek J. Pudil R, et al. Among authors: horacek jm. Leuk Res. 2008 Jun;32(6):998-9. doi: 10.1016/j.leukres.2007.09.020. Epub 2007 Nov 14. Leuk Res. 2008. PMID: 18001834 No abstract available.

4

Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.

Horacek JM, Pudil R, Tichy M, Jebavy L, Zak P, Slovacek L, Maly J. Horacek JM, et al. Exp Oncol. 2007 Sep;29(3):243-7. Exp Oncol. 2007. PMID: 18004253

5

New biomarkers of myocardial injury and assessment of cardiac toxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.

Horacek JM, Tichy M, Pudil R, Jebavy L, Zak P, Ulrychova M, Vavrova J, Maly J, Palicka V. Horacek JM, et al. Clin Chem Lab Med. 2008;46(1):148-9. doi: 10.1515/CCLM.2008.026. Clin Chem Lab Med. 2008. PMID: 18194085 No abstract available.

6

Assessment of anthracycline-induced cardiotoxicity with biochemical markers.

Horacek JM, Pudil R, Jebavy L, Tichy M, Zak P, Maly J. Horacek JM, et al. Exp Oncol. 2007 Dec;29(4):309-13. Exp Oncol. 2007. PMID: 18199989

7

Slovacek L, Slovackova B, Pavlik V, Hrstka Z, Macingova Z, Jebavy L, Horacek JM. Slovacek L, et al. Among authors: horacek jm. Neoplasma. 2008;55(4):350-5. Neoplasma. 2008. PMID: 18505348

8

Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia.

Horacek JM, Tichy M, Jebavy L, Pudil R, Ulrychova M, Maly J. Horacek JM, et al. Exp Oncol. 2008 Jun;30(2):157-9. Exp Oncol. 2008. PMID: 18566582

9

Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines.

Pudil R, Horacek JM, Strasova A, Jebavy L, Vojacek J. Pudil R, et al. Among authors: horacek jm. Exp Oncol. 2008 Jun;30(2):160-2. Exp Oncol. 2008. PMID: 18566583

10

Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity.

Horacek JM, Tichy M, Pudil R, Jebavy L. Horacek JM, et al. Ann Oncol. 2008 Sep;19(9):1656-7. doi: 10.1093/annonc/mdn414. Epub 2008 Jul 11. Ann Oncol. 2008. PMID: 18622008 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page